About Us

Pharmavic is a pharmaceutical company focused on providing medicines for hospital care and researching new therapeutic uses for existing and emerging medicines. Through strategic partnerships, including collaboration with Hplus, part of the HEFAME Group, we develop and manufacture medicines. Our work focuses on oncology, pain management and neurology.

Present and future

Our work is centred on therapeutic areas including oncology, pain, and neurology.

CEO Pharmavic

Juan Antonio Vargas Ramírez

Pharmavic represents an exciting challenge that drives us to become better every day. We are a pharmaceutical company made up of professionals with more than 20 years of experience in the pharmaceutical industry, where science is—and will always remain—our central and unwavering foundation.

our products

Injectable medicines

Oral medicines

C/Compositor Lehmberg Ruiz ,6
Edificio Ibiza, Oficina 7
29007 Málaga, Spain

Tel. +34 951 06 49 63

MAIL info@pharmavic.es

Legal notice | Privacy Policy | Cookie policy

“Pharmavic Iberica, S.L. has received an incentive from the Regional Ministry of Employment, Enterprise and Self-Employment of the Government of Andalusia, co‑funded by the European Union under the Andalucía ERDF Programme 2021–2027, for the implementation of a project aimed at improving the level of digitalisation, deploying solutions for digital transformation, and enhancing the security and reliability of processes in the commercial and artisan sectors of Andalusia.”

“Pharmavic Ibérica S.L. has been a beneficiary of European Funds aimed at strengthening sustainable growth and the competitiveness of SMEs. Thanks to this support, the company implemented an Action Plan to enhance its competitiveness through digital transformation, online promotion, and e‑commerce in international markets during the year 2025. This initiative was carried out with the support of the Xpande Digital Programme of the Málaga Chamber of Commerce. #EuropeFeelsIt”

Regional Ministry of Employment, Enterprise and Self‑Employment. Directorate‑General for Trade. PHARMAVIC IBÉRICA S.L. has been the beneficiary of the subsidy established by the Order of 27 December 2022, which sets out the regulatory bases for the granting of non‑competitive subsidies aimed at updating and boosting the commercial sector in Andalusia through the implementation of new technologies, within the Trade Modernisation Programme: Technological Fund, under the Recovery, Transformation and Resilience Plan – financed by the European Union – Next Generation EU. File No.: PYM222023SC000000344.

Funded by the European Union – Next Generation EU

Pharmavic SL has received an incentive from the Ministry of Industry and Tourism and the EOI Foundation through the ACTIVA STARTUPS Programme, funded by the European Union – Next Generation EU.

PHARMAVIC IBÉRICA S.L. has received an incentive from the Regional Ministry of Employment, Enterprise and Self‑Employment to support job placement and promote hiring within the Autonomous Community of Andalusia. This initiative is part of the Emplea‑T Programme, co‑funded by the FSE+ Andalusia 2021–2027 Programme.